Home Cart Sign in  
Chemical Structure| 1811-31-0 Chemical Structure| 1811-31-0
Chemical Structure| 1811-31-0

*Storage: Inert atmosphere,Store in freezer, under -20°C.

*Shipping: shipped in cold pack

D-N-Acetylgalactosamine

CAS No.: 1811-31-0

D-N-Acetylgalactosamine is an endogenous metabolite. It is commonly used in nucleic acid conjugate delivery systems, targeting the liver.

Synonyms: N-Acetylgalactosamine;GalNAc;N-Acetyl-D-galactosamine

4.5 *For Research Use Only !

Cat. No.: A455761 Purity: 95%

Change View

Size Price

USA Stock *0-1 Day

Global Stock *5-7 Days

In Stock
250mg łÇÿ¶ÊÊ Inquiry Inquiry Login
1g łÇó¶ÊÊ Inquiry Inquiry Login
5g łÍͶÊÊ Inquiry In Stock Login
10g łóͶÊÊ Inquiry Inquiry Login
25g łËÊ˶ÊÊ Inquiry Inquiry Login
100g łòóď¶ÊÊ Inquiry Inquiry Login

Please Login or Create an Account to: See VIP prices and availability

  • 250mg

    łÇÿ¶ÊÊ

  • 1g

    łÇó¶ÊÊ

  • 5g

    łÍͶÊÊ

  • 10g

    łóͶÊÊ

  • 25g

    łËÊ˶ÊÊ

  • 100g

    łòóď¶ÊÊ

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Details of [ 1811-31-0 ]

CAS No. :1811-31-0
Formula : C8H15NO6
M.W : 221.21
SMILES Code : CC(=O)N[C@@H](C=O)[C@@H](O)[C@@H](O)[C@H](O)CO
Synonyms :
N-Acetylgalactosamine;GalNAc;N-Acetyl-D-galactosamine
MDL No. :MFCD00135832
InChI Key :MBLBDJOUHNCFQT-OSMVPFSASA-N
Pubchem ID :92164

Safety of [ 1811-31-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 1811-31-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 15
Num. arom. heavy atoms 0
Fraction Csp3 0.75
Num. rotatable bonds 7
Num. H-bond acceptors 6.0
Num. H-bond donors 5.0
Molar Refractivity 48.42
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

127.09 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.41
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

-1.72
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

-3.23
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-2.73
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.4
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-1.73

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

0.33
Solubility 477.0 mg/ml ; 2.16 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Highly soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.44
Solubility 81.2 mg/ml ; 0.367 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.48
Solubility 6620.0 mg/ml ; 29.9 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

Low
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-8.87 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

3.14
 

Related Products

Historical Records

Technical Information

• Acyl Group Substitution • Appel Reaction • Barbier Coupling Reaction • Baylis-Hillman Reaction • Bucherer-Bergs Reaction • Buchwald-Hartwig C-N Bond and C-O Bond Formation Reactions • Chan-Lam Coupling Reaction • Chugaev Reaction • Clemmensen Reduction • Complex Metal Hydride Reductions • Corey-Chaykovsky Reaction • Corey-Fuchs Reaction • Corey-Kim Oxidation • Dess-Martin Oxidation • Fischer Indole Synthesis • Grignard Reaction • Hantzsch Dihydropyridine Synthesis • Heat of Combustion • Henry Nitroaldol Reaction • Horner-Wadsworth-Emmons Reaction • Hydride Reductions • Jones Oxidation • Julia-Kocienski Olefination • Knoevenagel Condensation • Lawesson's Reagent • Leuckart-Wallach Reaction • Mannich Reaction • Martin's Sulfurane Dehydrating Reagent • McMurry Coupling • Meerwein-Ponndorf-Verley Reduction • Mitsunobu Reaction • Moffatt Oxidation • Mukaiyama Aldol Reaction • Nozaki-Hiyama-Kishi Reaction • Oxidation of Alcohols by DMSO • Passerini Reaction • Paternò-Büchi Reaction • Petasis Reaction • Pictet-Spengler Tetrahydroisoquinoline Synthesis • Preparation of Alcohols • Preparation of Aldehydes and Ketones • Preparation of Amines • Prins Reaction • Reactions of Alcohols • Reactions of Aldehydes and Ketones • Reactions of Amines • Reactions with Organometallic Reagents • Reformatsky Reaction • Ritter Reaction • Schlosser Modification of the Wittig Reaction • Schmidt Reaction • Sharpless Olefin Synthesis • Specialized Acylation Reagents-Carbodiimides and Related Reagents • Specialized Acylation Reagents-Ketenes • Specialized Acylation Reagents-Vilsmeier Reagent • Stetter Reaction • Stobbe Condensation • Swern Oxidation • Tebbe Olefination • Ugi Reaction • Wittig Reaction • Wolff-Kishner Reduction

Categories

Related Functional Groups of
[ 1811-31-0 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 7512-17-6

A392657 [7512-17-6]

N-Acetyl-D-glucosamine

Similarity: 1.00

Chemical Structure| 5505-63-5

A126596 [5505-63-5]

(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride

Similarity: 0.72

Chemical Structure| 1772-03-8

A128462 [1772-03-8]

(2R,3R,4R,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride

Similarity: 0.72

Chemical Structure| 146439-94-3

A217554 [146439-94-3]

H-SER-ILE-LYS-VAL-ALA-VAL-OH

Similarity: 0.69

Chemical Structure| 81-13-0

A208721 [81-13-0]

(R)-2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide

Similarity: 0.66

Aldehydes

Chemical Structure| 7512-17-6

A392657 [7512-17-6]

N-Acetyl-D-glucosamine

Similarity: 1.00

Chemical Structure| 5505-63-5

A126596 [5505-63-5]

(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride

Similarity: 0.72

Chemical Structure| 1772-03-8

A128462 [1772-03-8]

(2R,3R,4R,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride

Similarity: 0.72

Chemical Structure| 55324-97-5

A168186 [55324-97-5]

(2R,3S,4R,5R)-6-Amino-2,3,4,5-tetrahydroxyhexanal hydrochloride

Similarity: 0.58

Alcohols

Chemical Structure| 7512-17-6

A392657 [7512-17-6]

N-Acetyl-D-glucosamine

Similarity: 1.00

Chemical Structure| 1292369-55-1

A220797 [1292369-55-1]

6-Hydroxyazepan-2-one

Similarity: 0.74

Chemical Structure| 68108-18-9

A181193 [68108-18-9]

(S)-4-Hydroxypyrrolidine-2-one

Similarity: 0.73

Chemical Structure| 62400-75-3

A204561 [62400-75-3]

5-(Hydroxymethyl)pyrrolidin-2-one

Similarity: 0.73

Chemical Structure| 17342-08-4

A213157 [17342-08-4]

(S)-(+)-5-Hydroxymethyl-2-pyrrolidinone

Similarity: 0.73

Amides

Chemical Structure| 7512-17-6

A392657 [7512-17-6]

N-Acetyl-D-glucosamine

Similarity: 1.00

Chemical Structure| 1292369-55-1

A220797 [1292369-55-1]

6-Hydroxyazepan-2-one

Similarity: 0.74

Chemical Structure| 68108-18-9

A181193 [68108-18-9]

(S)-4-Hydroxypyrrolidine-2-one

Similarity: 0.73

Chemical Structure| 62400-75-3

A204561 [62400-75-3]

5-(Hydroxymethyl)pyrrolidin-2-one

Similarity: 0.73

Chemical Structure| 17342-08-4

A213157 [17342-08-4]

(S)-(+)-5-Hydroxymethyl-2-pyrrolidinone

Similarity: 0.73

Amines

Chemical Structure| 7512-17-6

A392657 [7512-17-6]

N-Acetyl-D-glucosamine

Similarity: 1.00

Chemical Structure| 5505-63-5

A126596 [5505-63-5]

(2S,3R,4S,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride

Similarity: 0.72

Chemical Structure| 1772-03-8

A128462 [1772-03-8]

(2R,3R,4R,5R)-2-Amino-3,4,5,6-tetrahydroxyhexanal hydrochloride

Similarity: 0.72

Chemical Structure| 146439-94-3

A217554 [146439-94-3]

H-SER-ILE-LYS-VAL-ALA-VAL-OH

Similarity: 0.69

Chemical Structure| 23363-88-4

A231643 [23363-88-4]

N-(4-Hydroxycyclohexyl)acetamide(cis- and trans- mixture)

Similarity: 0.67